Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 2, 2017
Implications of the tumor immune microenvironment for staging and therapeuticsJanis M Taube, Jérôme Galon, Lynette M Sholl, et al.
Blood Advances|December 5, 2023
Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AMLJoshua A Fein, Roni Shouval, Elizabeth Krieger, et al.
The Lancet. Haematology|September 4, 2019
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysisRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Blood Advances|July 10, 2024
CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphomaPriyanka A Pophali, Joshua A Fein, Kwang W Ahn, et al.
Transplantation and Cellular Therapy|November 30, 2025
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative AnalysisMohammad Alhomoud, Glenn Heller, Christina Cho, et al.
Anesthesiology|April 17, 2004
Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacuriumJohn J Savarese, Matthew R Belmont, Mir A Hashim, et al.
Transplantation and Cellular Therapy|November 7, 2022
Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell LymphomaShalev Fried, Roni Shouval, Moneeza Walji, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York CityAlain C Borczuk, Steven P Salvatore, Surya V Seshan, et al.
Blood Advances|May 16, 2019
Clinicopathologic and genetic characterization of nonacute <i>NPM1</i>-mutated myeloid neoplasmsSanjay S Patel, Caleb Ho, Ryan N Ptashkin, et al.
Blood Advances|May 27, 2025
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantationIoannis Politikos, Samantha Brown, Joshua A Fein, et al.
Pageof 7